Home LiteratureArticle Details
PMID: 9525979 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis.

The Journal of clinical investigation ·Vol. 101 ·No. 7 ·1998-04-01 ·Pages 1372-8

Mueller BM, Ruf W

Abstract

Tissue factor (TF), the initiating cell surface receptor of the coagulation cascade, plays important roles in embryogenesis, angiogenesis, and tumor cell metastasis. It is controversial whether proteolytic function of TF complexed with its serine protease ligand VIIa is required for metastatic tumor dissemination. We show here in a model for TF-dependent experimental hematogenous metastasis, that TF supports metastasis by both proteolytic activity of the TF-VIIa complex and currently undefined functions of the cytoplasmic domain. We demonstrate that ligand binding of VIIa to TF is required for metastasis. Antimetastatic properties of covalently inactivated VIIa provide evidence that ligand binding is insufficient per se to support metastasis, emphasizing that proteolytic activity is necessary for the metastatic process. Ala or Asp mutations of cytoplasmic serine residues were introduced to preclude or mimic phosphorylation. In vivo analysis of these mutants suggests that local protease generation on the tumor cell surface does not serve simply to activate the cytoplasmic domain of TF by serine phosphorylation. Thus, extracellular functions of the catalytically active TF-VIIa complex cooperate with specific functions of the TF cytoplasmic domain to support the complex process of hematogenous tumor cell dissemination.

MeSH Terms
Animals CHO Cells Cricetinae Cytoplasm/metabolism Factor VIIa/metabolism Female Lung Neoplasms/secondary Mice Mice, SCID Neoplasm Metastasis Phosphorylation Structure-Activity Relationship Thromboplastin/chemistry,metabolism Transfection
Chemicals
Thromboplastin Factor VIIa
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Mueller B M
Department of Immunology, Scripps Research Institute, La Jolla, California 92037, USA. bmueller@scripps.edu
Ruf W
References (44)
44 references, click to expand
  1. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro.
    Cancer Res. 1994 Jun 1;54(11):3066-71 PMID: 8187097
  2. Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion.
    J Cell Biol. 1992 Nov;119(4):935-44 PMID: 1385447
  3. Factor VIIa residue Arg290 is required for efficient activation of the macromolecular substrate factor X.
    Biochemistry. 1994 Sep 27;33(38):11631-6 PMID: 7918377
  4. Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth.
    Clin Exp Metastasis. 1994 Nov;12(6):357-67 PMID: 7923988
  5. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.
    Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11832-6 PMID: 1465406
  6. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor.
    J Clin Invest. 1993 Jan;91(1):94-8 PMID: 8380817
  7. Thrombin receptor peptide inhibits thrombin-induced increase in endothelial permeability by receptor desensitization.
    J Cell Biol. 1993 Mar;120(6):1491-9 PMID: 8383691
  8. Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix.
    Int J Cancer. 1993 Apr 1;53(6):978-82 PMID: 8473056
  9. The urokinase receptor: involvement in cell surface proteolysis and cancer invasion.
    Ann N Y Acad Sci. 1992 Dec 4;667:13-31 PMID: 1339241
  10. A novel biologic activity of thrombin: stimulation of monocyte chemotactic protein production.
    J Exp Med. 1994 May 1;179(5):1737-41 PMID: 8163952
  11. Structural biology of tissue factor, the initiator of thrombogenesis in vivo.
    FASEB J. 1994 Apr 1;8(6):385-90 PMID: 8168689
  12. Tissue factor-initiated thrombin generation activates the signaling thrombin receptor on malignant melanoma cells.
    Cancer Res. 1995 Apr 15;55(8):1629-32 PMID: 7712465
  13. Energetic contributions and topographical organization of ligand binding residues of tissue factor.
    Biochemistry. 1995 May 16;34(19):6310-5 PMID: 7756258
  14. Regulation of the tissue factor gene.
    FASEB J. 1995 Jul;9(10):883-9 PMID: 7615158
  15. Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets.
    Cell. 1995 Aug 25;82(4):643-53 PMID: 7664343
  16. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation.
    Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8205-9 PMID: 7667269
  17. Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis.
    J Biol Chem. 1995 Oct 6;270(40):23730-8 PMID: 7559545
  18. Tissue factor expression in human leukocytes and tumor cells.
    Thromb Haemost. 1995 Jul;74(1):391-5 PMID: 8578492
  19. Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells.
    Am J Pathol. 1996 Jan;148(1):55-61 PMID: 8546226
  20. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect.
    EMBO J. 1996 Apr 1;15(7):1572-82 PMID: 8612581
  21. Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization.
    Arterioscler Thromb Vasc Biol. 1996 Mar;16(3):488-96 PMID: 8630677
  22. Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for an obligate autocrine mechanism promoting cell proliferation induced by G-protein-coupled receptor agonist.
    J Clin Invest. 1996 Mar 1;97(5):1173-83 PMID: 8636428
  23. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.
    Cell. 1996 May 31;85(5):683-93 PMID: 8646777
  24. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation.
    Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6258-63 PMID: 8692802
  25. Role of tissue factor in embryonic blood vessel development.
    Nature. 1996 Sep 5;383(6595):73-5 PMID: 8779717
  26. Steps in tumor metastasis: new concepts from intravital videomicroscopy.
    Cancer Metastasis Rev. 1995 Dec;14(4):279-301 PMID: 8821091
  27. Association of tissue factor with a gamma chain homodimer of the IgE receptor type I in cultured human monocytes.
    Eur J Immunol. 1996 Oct;26(10):2529-32 PMID: 8898969
  28. Integrins and cancer.
    Curr Opin Cell Biol. 1996 Oct;8(5):724-30 PMID: 8939661
  29. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
    Cancer Res. 1996 Dec 1;56(23):5309-18 PMID: 8968075
  30. Plaque rupture, thrombosis, and therapeutic implications.
    Haemostasis. 1996 Oct;26 Suppl 4:269-84 PMID: 8979133
  31. Influence of mutations in tissue factor on the fine specificity of macromolecular substrate activation.
    Biochem J. 1997 Feb 1;321 ( Pt 3):787-93 PMID: 9032467
  32. Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor.
    J Biol Chem. 1997 May 2;272(18):11863-8 PMID: 9115245
  33. Tissue factor in cancer angiogenesis and metastasis.
    Curr Opin Hematol. 1996 Sep;3(5):379-84 PMID: 9372105
  34. Leech salivary gland extract from Haementeria officinalis, a potent inhibitor of cyclophosphamide- and radiation-induced artificial metastasis enhancement.
    Cancer Res. 1984 Dec;44(12 Pt 1):5670-6 PMID: 6498828
  35. Metastatic inefficiency.
    Adv Cancer Res. 1990;54:159-211 PMID: 1688681
  36. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.
    Cancer Res. 1990 Oct 1;50(19):6130-8 PMID: 1698118
  37. The integrity of the cysteine 186-cysteine 209 bond of the second disulfide loop of tissue factor is required for binding of factor VII.
    J Biol Chem. 1991 Jun 5;266(16):10294-9 PMID: 2037582
  38. Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor.
    Cancer Res. 1991 Sep 1;51(17):4549-56 PMID: 1873799
  39. Lipid association, but not the transmembrane domain, is required for tissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor.
    J Biol Chem. 1991 Nov 15;266(32):21911-6 PMID: 1834663
  40. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism.
    J Biol Chem. 1992 Feb 25;267(6):3561-4 PMID: 1740409
  41. An anti-tissue factor monoclonal antibody which inhibits TF.VIIa complex is a potent anticoagulant in plasma.
    Thromb Haemost. 1991 Nov 1;66(5):529-33 PMID: 1803616
  42. Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease complex.
    J Biol Chem. 1992 Mar 25;267(9):6375-81 PMID: 1372908
  43. Tissue factor as a tumor procoagulant.
    Cancer Metastasis Rev. 1992 Nov;11(3-4):249-66 PMID: 1423817
  44. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.
    J Clin Invest. 1994 Sep;94(3):1320-7 PMID: 7521887
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1998-04-01
Pages
1372-8
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC508714
Subset
IM
Grants
NCI NIH HHS · CA-59692 · United States
NHLBI NIH HHS · HL-16411 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com